Literature DB >> 1969461

Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis.

M Zaffaroni1, S Rossini, A Ghezzi, R Parma, C L Cazzullo.   

Abstract

Circulating lymphocyte subpopulations defined by anti-CD45 and other more common T-cell-specific monoclonal antibodies were analysed in 77 patients with multiple sclerosis and 38 healthy controls. A selective decrease of CD4+CD45+ cell percentages and absolute numbers in chronic-progressive patients was found; in 13 out of 26 patients this subpopulation was less than 11% CD4+CD45+ cells. Similarly, the whole CD45+ cell subset, as well as CD45+ cells expressed as percentages of CD4+ cells, were significantly reduced in chronic-progressive multiple sclerosis. CD4+CD45+ cells, commonly termed "inducer of suppression" T-lymphocytes, did not correlate with percentages or numbers of CD8+ cells. It is concluded that suppressor inducer T-cells act on the CD8+ subset function rather than reducing CD8+ cell numbers. Since CD4+CD45+ cells represent an early stage of lymphocyte maturation (naive T-cells), an under-representation of this subpopulation in active multiple sclerosis might reflect an increased conversion of naive cells into memory cells. This concept may be relevant for a better understanding of the disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969461     DOI: 10.1007/bf00319659

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.

Authors:  M Chofflon; H L Weiner; C Morimoto; D A Hafler
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

3.  The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions.

Authors:  R A Sobel; D A Hafler; E E Castro; C Morimoto; H L Weiner
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

4.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells.

Authors:  C Morimoto; N L Letvin; C E Rudd; M Hagan; T Takeuchi; S F Schlossman
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

6.  Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.

Authors:  M Chofflon; H L Weiner; C Morimoto; D A Hafler
Journal:  Ann Neurol       Date:  1988-08       Impact factor: 10.422

Review 7.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

8.  Diurnal variation of lymphocyte subsets identified by monoclonal antibodies.

Authors:  J V Bertouch; P J Roberts-Thomson; J Bradley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

9.  Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis.

Authors:  L M Rose; A H Ginsberg; T L Rothstein; J A Ledbetter; E A Clark
Journal:  Ann Neurol       Date:  1988-08       Impact factor: 10.422

10.  Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

Authors:  C Morimoto; D A Hafler; H L Weiner; N L Letvin; M Hagan; J Daley; S F Schlossman
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

View more
  7 in total

1.  CD4+ lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases.

Authors:  M Zaffaroni; L Gallo; A Ghezzi; C L Cazzullo
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

2.  Evidence for a missed signal to the CD8+ cells in CSF of multiple sclerosis patients.

Authors:  M Saresella; A Grope; L Speciale; R Mancuso; R De Benedictis; D Caputo; P Ferrante
Journal:  Ital J Neurol Sci       Date:  1995-10

3.  Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Memory and naive CD4+ lymphocytes in multiple sclerosis.

Authors:  A M Porrini; D Gambi; G Malatesta
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

Review 5.  Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response.

Authors:  Noymar Luque-Campos; Rafael A Contreras-López; María Jose Paredes-Martínez; Maria Jose Torres; Sarah Bahraoui; Mingxing Wei; Francisco Espinoza; Farida Djouad; Roberto Javier Elizondo-Vega; Patricia Luz-Crawford
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 6.  Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.

Authors:  Tanima Bose
Journal:  Brain Sci       Date:  2017-11-07

7.  Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis.

Authors:  Maria Sofia Basile; Emanuela Mazzon; Katia Mangano; Manuela Pennisi; Maria Cristina Petralia; Salvo Danilo Lombardo; Ferdinando Nicoletti; Paolo Fagone; Eugenio Cavalli
Journal:  Brain Sci       Date:  2020-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.